Motegrity Alternatives
Drugs like Motegrity (prucalopride) — other gastrointestinal medications advertised on TV that may be alternatives. Informational only — not medical advice. Only your doctor can decide what's right for you.
Unverified catalogue summary (alternative grouping) for Motegrity in US; not checked against current local product information.
Linzess
linaclotide · AbbVie Inc./Ironwood Pharmaceuticals, Inc. (US marketers)
Treats IBS with constipation (age 7+), adult chronic idiopathic constipation, pediatric functional constipation (age 2+)
Unverified catalogue summary (alternative identity, manufacturer and indication) for Linzess in US; not checked against current local product information.
Rezdiffra
resmetirom · Madrigal Pharmaceuticals
Treats Metabolic dysfunction-associated steatohepatitis (MASH)
Unverified catalogue summary (alternative identity, manufacturer and indication) for Rezdiffra in US; not checked against current local product information.
Trulance
plecanatide · Salix (Bausch Health)
Treats Chronic idiopathic constipation and IBS-C
Unverified catalogue summary (alternative identity, manufacturer and indication) for Trulance in US; not checked against current local product information.
Ibsrela
tenapanor · Ardelyx
Treats Irritable bowel syndrome with constipation (IBS-C)
Unverified catalogue summary (alternative identity, manufacturer and indication) for Ibsrela in US; not checked against current local product information.
Viberzi
eluxadoline · AbbVie
Treats Irritable bowel syndrome with diarrhea
Unverified catalogue summary (alternative identity, manufacturer and indication) for Viberzi in US; not checked against current local product information.
Sources and editorial standards
Product-label references, not clinical verification. Medicine identification—not prescribing guidance. This page does not provide a complete safety or dosing reference. Check the official label for your country and exact product, and consult your pharmacist or prescriber before starting, stopping or changing treatment. Missing information does not mean a medicine is safe for you. Reference formulation scope (not dosing instructions): 1 mg and 2 mg oral prucalopride tablets
Unresolved / not established by these sources:
- Clinical summaries, safety tiers and dosing guidance are withheld while their review remains unfinished.
- A linked document may have been superseded. Confirm country, product, formulation and latest revision with the regulator or pharmacist.
- US label reference: Motegrity: full US prescribing information, SPL v12, published 2025-07-21
Manufacturer label · Reference scope: Reference link only. Verify the exact formulation and current revision; this does not certify a clinical summary.
Lookup resources (not product-specific citations; confirm formulation and country before use):
Frequently asked questions
What drugs are similar to Motegrity?
Unverified catalogue grouping, not a clinically established substitute or a checked local indication. Drugs like Motegrity include other gastrointestinal medications advertised on TV such as Linzess, Rezdiffra, Trulance and more. This is an editorial catalogue grouping, not a verified comparison of indications, safety or suitable substitutes. Ask your prescriber about treatment choices.
What can I take instead of Motegrity?
Unverified catalogue grouping, not a clinically established substitute or a checked local indication. Other gastrointestinal medications advertised on TV include Linzess, Rezdiffra, Trulance and others. The right alternative depends on your diagnosis, medical history and insurance — only your doctor can recommend a substitute for Motegrity. This page is informational only.
Is there a generic version of Motegrity?
Unverified catalogue grouping, not a clinically established substitute or a checked local indication. Motegrity is sold as prucalopride. Whether a lower-cost generic is available depends on patent status — ask your pharmacist, and see the cost & savings page for ways to pay less.
Are these alternatives the same as Motegrity?
Unverified catalogue grouping, not a clinically established substitute or a checked local indication. This catalogue grouping does not establish therapeutic equivalence, shared approved indications or suitability as a substitute. Do not switch medicines based on it; consult your prescriber.